Results 291 to 300 of about 1,937,940 (311)
Some of the next articles are maybe not open access.
The Lancet, 1999
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable.
D F, Schafer, M F, Sorrell
openaire +2 more sources
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable.
D F, Schafer, M F, Sorrell
openaire +2 more sources
Immunotherapies for hepatocellular carcinoma
Nature Reviews Clinical Oncology, 2021J. Llovet +8 more
semanticscholar +1 more source
Nature Reviews Clinical Oncology, 2023
Amit G. Singal, F. Kanwal, J. Llovet
semanticscholar +1 more source
Amit G. Singal, F. Kanwal, J. Llovet
semanticscholar +1 more source
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.
Cancer metastasis reviews, 2023Yu Wang, B. Deng
semanticscholar +1 more source
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
Journal of Hepatology, 2018P. Galle +7 more
semanticscholar +1 more source
Hepatocellular Carcinoma: New Developments.
Clinical Liver Disease, 2023Previn Ganesan, L. Kulik
semanticscholar +1 more source
Biomarkers for immunotherapy of hepatocellular carcinoma
Nature Reviews Clinical Oncology, 2023Tim F Greten +7 more
semanticscholar +1 more source
Evolving therapeutic landscape of advanced hepatocellular carcinoma
Nature reviews: Gastroenterology & hepatology, 2022Chen Yang +6 more
semanticscholar +1 more source